DE3767055D1 - N-(2,6-dichlor-m-tolyl)anthranilsaeure (mechlophenaminsaeure) enthaltenden gel-arzneiform zur verwendung in der lokaltherapie. - Google Patents

N-(2,6-dichlor-m-tolyl)anthranilsaeure (mechlophenaminsaeure) enthaltenden gel-arzneiform zur verwendung in der lokaltherapie.

Info

Publication number
DE3767055D1
DE3767055D1 DE8787830254T DE3767055T DE3767055D1 DE 3767055 D1 DE3767055 D1 DE 3767055D1 DE 8787830254 T DE8787830254 T DE 8787830254T DE 3767055 T DE3767055 T DE 3767055T DE 3767055 D1 DE3767055 D1 DE 3767055D1
Authority
DE
Germany
Prior art keywords
acid
mechlophenamic
dichlor
tolyl
form containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787830254T
Other languages
English (en)
Inventor
Raffaello Bani
Mario Ghelardoni
Francesco Melani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menarini Industrie Farmaceutiche Riunite SRL
Original Assignee
Menarini Industrie Farmaceutiche Riunite SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Industrie Farmaceutiche Riunite SRL filed Critical Menarini Industrie Farmaceutiche Riunite SRL
Application granted granted Critical
Publication of DE3767055D1 publication Critical patent/DE3767055D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE8787830254T 1986-07-02 1987-07-02 N-(2,6-dichlor-m-tolyl)anthranilsaeure (mechlophenaminsaeure) enthaltenden gel-arzneiform zur verwendung in der lokaltherapie. Expired - Fee Related DE3767055D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8609429A IT1216233B (it) 1986-07-02 1986-07-02 Utilizzazione della forma farmaceutica 'gel'contenente acido n (2,6 dicloro m tolil) antranilico (acido meclofenamico) impiegabile in terapia per uso topico.

Publications (1)

Publication Number Publication Date
DE3767055D1 true DE3767055D1 (de) 1991-02-07

Family

ID=11130019

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787830254T Expired - Fee Related DE3767055D1 (de) 1986-07-02 1987-07-02 N-(2,6-dichlor-m-tolyl)anthranilsaeure (mechlophenaminsaeure) enthaltenden gel-arzneiform zur verwendung in der lokaltherapie.

Country Status (8)

Country Link
EP (1) EP0252033B1 (de)
JP (1) JPS6322518A (de)
AT (1) ATE59292T1 (de)
CA (1) CA1304687C (de)
DE (1) DE3767055D1 (de)
ES (1) ES2033927T3 (de)
GR (1) GR3001613T3 (de)
IT (1) IT1216233B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933172A (en) * 1988-10-06 1990-06-12 Warner-Lambert Co. Method of and compositions for treating destructive periodontal disease
US5386440A (en) * 1992-01-10 1995-01-31 Hitachi, Ltd. Boiling water reactor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1402282A (en) * 1972-09-07 1975-08-06 Ward P E Preparation for skin treatment
IT1124398B (it) * 1979-12-05 1986-05-07 Menarini Sas Utilizzazione della forma farmaceutica gel contenente acido 23 benzoilfenil propionico impiegabile in terapia per uso topico
JPS5976013A (ja) * 1982-10-23 1984-04-28 Toko Yakuhin Kogyo Kk 外用ゲル製剤
CA1229554A (en) * 1983-04-18 1987-11-24 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
DE3381733D1 (de) * 1983-12-08 1990-08-16 Toko Yakuhin Kogyo Kk Gelpraeparate zur externen applikation.

Also Published As

Publication number Publication date
GR3001613T3 (en) 1992-11-23
EP0252033A3 (en) 1988-03-30
EP0252033A2 (de) 1988-01-07
EP0252033B1 (de) 1990-12-27
IT8609429A0 (it) 1986-07-02
ATE59292T1 (de) 1991-01-15
IT1216233B (it) 1990-02-22
ES2033927T3 (es) 1993-04-01
CA1304687C (en) 1992-07-07
JPS6322518A (ja) 1988-01-30

Similar Documents

Publication Publication Date Title
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
ATE227587T1 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DE3780618D1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
BR9403783A (pt) Uso de uma composição cosmética
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
ATE69548T1 (de) Vitamin e-haltiges mittel zur verbesserung der eigenschaften des blutes.
ATE79536T1 (de) Tamoxifen zur topischen verwendung.
ATE86488T1 (de) Verwendung von minoxidil zur wundheilung.
DK1032378T3 (da) Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme
IT1182854B (it) Composizione anestesica percutanea per impiego topico e procedimento d'applicazione
DK0579488T3 (da) Præparat til behandling af mastitis og matritis
FI852730A0 (fi) (pyrrol-1-yl) -fenyl-dihydropyridazinoner, deras framstaellning och anvaendning.
DE3767055D1 (de) N-(2,6-dichlor-m-tolyl)anthranilsaeure (mechlophenaminsaeure) enthaltenden gel-arzneiform zur verwendung in der lokaltherapie.
DE59401990D1 (de) Imidazolyl-substituierte Phenylessigsäureprolinamide
FR2544718B1 (fr) Diniflumate d'ester morpholinoethylique d'acide niflumique, preparation, utilisation en therapeutique comme analgesique et anti-inflammatoire
FI851365A0 (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
BR9704964A (pt) Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais
DE3771548D1 (de) Verwendung von carbonsaeure in fuer topische anwendung vorgesehenen pharmazeutischen zubereitungen.
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
DK222988A (da) Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer
MY102063A (en) New use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
IT8520282A0 (it) Procedimento per migliorare le proprieta' del cemento, e cemento cosi' ottenuto.
ATE46083T1 (de) Arzneimittel zur topischen anwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee